Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: Relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway

Diabetologia

Volumn 41, Issue 11, 1998, Pages 1343-1354

  Zierath, J R ^a   Livingston, J N ^b   Thörne, Anders ^a   Bolinder, Jan ^a   Reynisdottir, Signy ^a   Lönnqvist, Fredrik ^a   Arner, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b BAYER CORPORATION   (United States)

Author keywords

Catecholamines; Insulin receptor substrate 1; Lipolysis; Phosphaditylinositol 3 kinase; Re esterification; Tyrosine kinase

Indexed keywords

CATECHOLAMINE; FATTY ACID; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE KINASE;

ADIPOCYTE; ARTICLE; CONTROLLED STUDY; ESTERIFICATION; FATTY ACID METABOLISM; FEMALE; HORMONE ACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; VISCERA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOCYTES; ADIPOSE TISSUE; ADULT; AGED; FATTY ACIDS, NONESTERIFIED; FEMALE; GLYCEROL; HUMANS; INSULIN; KINETICS; LIPOLYSIS; MALE; MIDDLE AGED; NOREPINEPHRINE; OMENTUM; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; RECEPTOR, INSULIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN; TRANSCRIPTION, GENETIC;

EID: 0031739240     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051075     Document Type: Article

References (40)

1. Kahn CR (1994) Insulin action, diabetogenesis and the cause of Type II diabetes. Diabetes 43: 1066-1084, 16: 2, 117
2. Kahn CR (1994) Insulin action, diabetogenesis and the cause of Type II diabetes. Diabetes 43: 1066-1084, 16: 2, 117
3. Lee J, Pilch PF (1994) The insulin receptor: structure, function, and signalling. Am J Physiol 266:C319-C334
4. White MF, Khan RC (1994) The insulin signalling system. Biochem Mol 269: 1
5. Quon MJ, Butte AJ, Taylor I (1994) Insulin signal transduction pathways. Trends Endocrinol Metab 5: 369-376
6. Arner P (1992) Metabolism of fatty acids: an overview. In: Bray G, Ricquier D, Spiegelman BM (eds) Obesity, JB Lippincott Co., Philadelphia, pp 294-308
7. Fry MJ (1994) Structure, regulation and function of phosphoinositide 3-kinases. Biochimica et Biophysica Acta 1226: 237-268
8. Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M (1994) Essential role of phospatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem 269: 3568-3573
9. Lam K, Carpenters CL, Ruderman NB, Friel JC, Kelly KL (1994) The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by wortmannin. J Biol Chem 269: 20648-20652
10. Rahn T, Ridderstråle M, Tornqvist H et al. (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes. Studies using the selective inhibitor wortmannin. FEBS Lett 350: 314-318
11. Leibel RL, Edens NK, Fried SK (1989) Physiological basis for the control of body fat distribution in humans. Annu Rev Nutr 9: 417-443
12. Kissebah AH, Krakower GR (1994) Regional adiposity and morbidity. Physiol Rev 74: 761-811
13. Lemieux S, Després JP (1994) Metabolic complications of visceral obesity: contribution to the aetiology of Type II diabetes and implications for prevention and treatment. Diabetes Metab 20: 375-393
14. Abat N, Garg A (1995) Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity. Prog Lipid Res 34: 53-70
15. Bolinder J, Kager L, Östman J, Arner P (1983) Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes 32: 117-123
16. Livingston JN, Lerea KM, Bolinder J, Kager L, Backman L, Arner P (1984) Binding and molecular weight properties of the insulin receptor from omental and subcutaneous adipocytes in human obesity. Diabetologia 27: 447-453
17. 3-adrenoceptors in obesity. J Clin Invest 1109-1116
18. Hellmér J, Arner P, Lundin A (1989) Automatic luminometric kinetic assay of glycerol for lipolysis studies. Anal Biochem 177: 132-137
19. Edens NK, Leibel RL, Hirsch J (1990) Mechanism of free fatty acid re-esterification in human adipocytes in vitro. J Lipid Res 31: 1423-1431
20. Näslund B, Bernström K, Lundin A, Arner P (1993) Release of small amounts of free fatty acids from human adipocytes as determined by chemiluminescence. J Lipid Res 34: 633-642
21. Arner P (1995) Techniques for the measurement of white adipose tissue metabolism: a practical guide. Int J Obes 19: 435-442
22. Norgren S, Arner P, Luthman H (1994) Insulin receptor ribonucleic acid levels and alternative splicing in human liver, muscle and adipose tissue: tissue specificity and relation to insulin action. J Clin Endocrinol Metab 78: 757-762
23. Liu R, Zhu J, Jospe N, Furlanetto RW, Bastian W, Livingston JN (1995) Deletion of tysine 1.21 and creates a temperature-sensitive alteration in insulin binding by the insulin receptor. J Biol Chem 270: 476-482
24. Goodyear LA, Giorgino F, Sherman LA, Carey JO, Smith RJ, Dohm GL (1995) Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest 95: 2195-2204
25. Jackson TR, Stephens LR, Hawkins PT (1992) Receptor specificity of growth factor-stimulated synthesis of 3-phosphorylated inositol lipids in Swiss 3T3 cells. J Biol Chem 267: 16627-16636
26. Thomas SHL, Wisher MH, Brandenburg D, Sönksen PH (1979) Evidence that the anti-lipolytic and lipogenic effects of insulin are mediated by the same receptor. Biochem J 184: 355-360
27. Kenakin T (1984) The classification of drugs and drug receptors in isolated tissue. Pharmacol Rev 36: 165-214
28. Kahn CR (1978) Insulin resistance, insulin sensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism 27: 1893-1902
29. Rice KM, Turnbow MA, Garner CW (1993) Insulin stimulates the degradation of IRS-1 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 190: 961-967
30. Sun XJ, Wang LM, Zhang Y et al. (1995) Role of IRS-2 in insulin and cytokine signalling. Nature 377: 173-177
31. Lavan BE, Lane WS, Lienhard GE (1977) The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272: 11439-11443
32. Rondinone CM, Wang LM, Lonnroth P, Wesslau C, Pierce JH, Smith U (1977) Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 94: 4171-1175
33. Zierler KL, Rabinovitz B (1964) Effect of very small concentrations of insulin on forearm metabolism. Persistence of its action of potassium and free fatty acids without its effect on glucose. J Clin Invest 43: 950-962
34. Pedersen O, Gliemann J (1981) Hexose transport in human adipocytes: factors influencing the response to insulin and kinetics of methylglucose and glucose transport. Diabetologia 20: 630-635
35. Thies RS, Molina JM, Ciaraldi TP, Freidenberg GR, Olefsky JM (1990) Insulin-receptor autophosphorylation and endogenous substrate phosphorylation in human adipocytes from control, obese and NIDDM subjects. Diabetes 39: 250-259
36. Leibel RL, Forse RA, Hirsch J (1989) Effects of rapid glucose infusion on in vivo and in vitro free fatty acid re-esterification by adipose tissue of fasted obese subjects. Int J Obesity 13: 661-671
37. Manganiello VC, Vaughan M (1973) An effect of insulin on cyclic adenosine 3 ′, 5 ′-monophosphate phosphodiesterase activity in fat cells. J Biol Chem 248: 7164
38. Goldstein BJ (1993) Regulation of insulin receptor signalling by protein-tyrosine dephosphorylation. Receptor 3: 1-15
39. Ahmad F, Considine RV, Goldstein BJ (1995) Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects. J Clin Invest 95: 2806-2812
40. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chrisholm DJ, Campbell LV (1993) The relationship between insulin sensitivity and the fatty acid composition of the phospholipids of skeletal muscle. N Engl J Med 328: 238-244